Xultophy is a medicine that is used for the treatment of type 2 diabetes. Together with diet and exercise, Xultophy is added to treatment with diabetes medicines taken by mouth when these medicines, alone or with other injections, have not controlled blood glucose (sugar) levels. The active substances in Xultophy are insulin degludec and liraglutide.
Therapeutic Indication
### Therapeutic indication Xultophy is indicated for the treatment of adults with type-2 diabetes mellitus to improve glycaemic control in combination with oral glucose-lowering medicinal products when these alone or combined with a GLP-1 receptor agonist or basal insulin do not provide adequate glycaemic control.
Therapeutic Area (MeSH)
ATC Code
A10AE56
ATC Item
insulin degludec and liraglutide
Pharmacotherapeutic Group
Drugs used in diabetes
Active Substance (Summary)
INN / Common Names
EMA Name
Xultophy
Medicine Name
Xultophy
Aliases
N/ANo risk management plan link.
